Toshinai K, Nakazato M
Neurology, Respirology, Endocrinology and Metabolism, Division of Internal Medicine, Faculty of Medicine, University of Miyazaki, Kiyotake, Miyazaki, 889-1692, Japan.
Cell Mol Life Sci. 2009 Jun;66(11-12):1939-45. doi: 10.1007/s00018-009-8796-0.
Neuroendocrine regulatory peptides (NERP)-1 and NERP-2 are derived from distinct regions of VGF, a neurosecretory protein that was originally identified as a product of a nerve growth factor-responsive gene in rat PC12 cells. The amino acid length of human NERP-1 is 26, and that of rat NERP-1 is 25. Human and rat NERP-2 are both 38 amino acid peptides. NERPs colocalize with vasopressin in the storage granules of the paraventricular and supraoptic nuclei in the hypothalamus of both rats and humans. Administration of NERPs suppresses hypertonic saline- or angiotensin II-induced vasopressin release from the hypothalamus and pituitary. Thus, VGF is a precursor of multiple bioactive peptides with diverse neuroendocrine functions, and NERPs are novel hypothalamic peptides involved in the control of body fluid homeostasis by regulating vasopressin release.
神经内分泌调节肽(NERP)-1和NERP-2源自VGF的不同区域,VGF是一种神经分泌蛋白,最初被鉴定为大鼠PC12细胞中神经生长因子反应基因的产物。人NERP-1的氨基酸长度为26,大鼠NERP-1的氨基酸长度为25。人和大鼠的NERP-2均为38个氨基酸的肽。在大鼠和人类下丘脑的室旁核和视上核的储存颗粒中,NERP与加压素共定位。给予NERP可抑制高渗盐水或血管紧张素II诱导的下丘脑和垂体加压素释放。因此,VGF是具有多种神经内分泌功能的多种生物活性肽的前体,而NERP是通过调节加压素释放参与控制体液稳态的新型下丘脑肽。